Validation of a method using an achiral liquid chromatography sorbent and a circular dichroism detector. Analysis of the efaroxan enantiomers

Journal of Chromatography A

Volumn 1141, Issue 2, 2007, Pages 244-250

  Lorin, Marie ^a   Delépée, Raphaël ^a   Ribet, Jean Paul ^b   Morin, Philippe ^a  

^a Université d'Orléans   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Anisotropy factor (g factor); C8 silica column; Circular dichroism (CD); Efaroxan; Enantiomeric excess (e.e.); HPLC; Non enantioselective HPLC CD

Indexed keywords

CORRELATION METHODS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR STRUCTURE; STATISTICAL METHODS; ULTRAVIOLET DETECTORS;

ANISOTROPY FACTORS (G FACTOR); CIRCULAR DICHROISM (CD); EFAROXAN;

SILICA;

EFAROXAN; SILICON DIOXIDE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CIRCULAR DICHROISM; DRUG DETERMINATION; DRUG PURITY; ENANTIOMER; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; OPTICAL ROTATION; PRIORITY JOURNAL; VALIDATION PROCESS;

BENZOFURANS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; IMIDAZOLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 33846255498     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2006.12.036     Document Type: Article

References (28)

1. Anastasiadis P.Z., Jiang H., Bezin L., Kuhn D.M., and Levine R.A. J. Biol. Chem. 276 (2001) 9050
2. Hurley M.J., and Jenner P. Pharmacol. Ther. 116 (2006) 715
3. Schrag A. J. Neurol. 251 (2004) 795
4. Tellez S., Colpaert F., and Marien M. Eur. J. Pharmacol. 277 (1995) 113
5. Silveira G.D.P., and Coelho F. Tetrahedron Lett. 46 (2005) 6477
6. Pena R., Ribet J.P., Maurel J.L., Valat L., Lacoulonche F., and Chauvet A. Thermochim. Acta 408 (2003) 85
7. Lipka-Belloli E., Glaçon V., Mackenzie G., Ewing D., Len C., Vaccher C., and Bonte J.-P. J. Chromatogr. A 972 (2002) 211
8. Aboul-Enein H.Y., Ali I., Gübitz G., Simons C., and Nicholls P.J. Chirality 12 (2000) 727
9. Péter A., Arki A., Forro E., Fülöp F., and Armstrong D.W. Chirality 17 (2005) 193
10. Welch C.J., Kress M.H., Beconi M., and Mathre D.J. Chirality 15 (2003) 143
11. Rudaz S., and Veuthey J.-L. Chirality 11 (1999) 319
12. Grard S., Morin Ph., Dreux M., and Ribet J.-P. Electrophoresis 21 (2000) 3028
13. Bobbitt D.R., and Linder S.W. Trends Anal. Chem. 20 (2001) 111
14. Taniguchi T., Miura N., Nishimura S.-I., and Monde K. Mol. Nutr. Food Res. 48 (2004) 246
15. Reetz M.T., Kühling K.M., Hinrichs H., and Deege A. Chirality 12 (2000) 479
16. Bertucci C., Andrisano V., Cavrini V., and Castiglioni E. Chirality 12 (2000) 84
17. Bossu E., Cotichini V., Gostoli G., and Farina A. J. Pharm. Biomed. Anal. 26 (2001) 837
18. Hadley M.R., and Jonas G.D. Enantiomer 5 (2000) 357
19. Kudo K., Iwaya K., Yomota C., Morris S., and Saito M. Enantiomer 5 (2000) 369
20. M. Lorin, R. Delepee, J.-C. Maurizot, J.-P. Ribet, Ph. Morin, Chirality, doi:10.1002/chir.20352, in press.
21. Caporal-Gauthier J., Nivet J.M., Algranti P., Guilloteau M., Histe M., N'Guyen-Huu J.J., and Russotto R. STP Pharma Pratiques 2 (1992) 205
22. Eliel E.L. Chirality 9 (1997) 428
23. Blanco M., Coello J., Iturriaga H., Maspoch S., and Perez-Maseda C. Anal. Chim. Acta 407 (2000) 233
24. Nishino H., Kosaka A., Hembury G.A., Matsushima K., and Inoue Y. J. Chem. Soc., Perkin Trans. 2 2 (2002) 582
25. ICH Q2B: Validation of Analytical Procedures: Methodology (International Conference on Harmonization of Technical Requirements for the Drugs Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, May 1997).
26. Miller M.T., Ge Z., and Mao B. Chirality 14 (2002) 659
27. Williams R.C., Edwards J.F., Joshi A.S., and Aubry A.-F. J. Pharm. Biomed. Anal. 25 (2001) 501
28. Beaufour M., Morin Ph., Ribet J.-P., and Maurizot J.-C. J. Pharm. Biomed. Anal. 41 (2006) 544